Announce Date | 04/28/2025 |
EPS Normalized Actual | $1.67 (Beat by $0.45) |
EPS GAAP Actual | $1.67 (Beat by $0.45) |
Revenue Actual | $2.887B |
Revenue Surprise | Beat by $2887M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.825 |
EPS GAAP Estimate | $1.825 |
Revenue Estimate | $3.184175B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 7.77 | 13.77 | 7.51404 | 8.2494 | 1 |
Dec 2026 | 6.655 | 16.08 | 6.36 | 7.02 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.65 | 1.65 | 2.887B | 3.57% | 2887M |
FQ4 2024 (Dec 2024) | 3.03 | 3.03 | 2.903B | 1.55% | 2903M |
FQ3 2024 (Sep 2024) | -1.47 | -1.47 | 3.074B | 0.16% | 3074M |
FQ2 2024 (Jun 2024) | 1.45 | 1.45 | 3.04B | -2.27% | 3040M |
FQ1 2024 (Mar 2024) | 0.56 | 0.56 | 2.784B | -6.82% | 2784M |
FQ4 2023 (Dec 2023) | 0.7 | 0.7 | 2.858B | -5.39% | 2858M |
FQ3 2023 (Sep 2023) | 1.33 | 1.33 | 3.069B | -6.19% | 3069M |
FQ2 2023 (Jun 2023) | 1.31 | 1.31 | 3.109B | -12.9% | 3109M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.825
Consensus Revenue Estimates
3.184175B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.8939 | -- | 1.83443 | 2.04256 | 5 |
FQ3 2027 (Sep 2027) | 2.4542 | -- | 2.37714 | 2.64684 | 2 |
FQ2 2027 (Jun 2027) | 2.1955 | -- | 2.12656 | 2.36783 | 2 |
FQ1 2027 (Mar 2027) | 1.3586 | -- | 1.31594 | 1.46524 | 2 |
FQ4 2026 (Oct 2026) | 2.22771 | -- | 2.22771 | 2.22771 | 3 |
FQ3 2026 (Jul 2026) | 1.99423 | -- | 1.99423 | 1.99423 | 3 |
FQ2 2026 (Jun 2026) | 1.99423 | -- | 1.92425 | 2.0671 | 11 |
FQ1 2026 (Mar 2026) | 1.59381 | -3.53 | 1.53788 | 1.65205 | 10 |
FQ4 2025 (Oct 2025) | 2.01 | -50.75 | 1.94802 | 2.08774 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.18B | -- | 3.1B | 3.37B | 3 |
FQ3 2027 (Sep 2027) | 3.17B | -- | 3.09B | 3.36B | 3 |
FQ2 2027 (Jun 2027) | 3.16B | -- | 3.08B | 3.35B | 3 |
FQ1 2027 (Mar 2027) | 3.15B | -- | 3.08B | 3.34B | 3 |
FQ4 2026 (Oct 2026) | 3.3B | -- | 3.3B | 3.3B | 4 |
FQ3 2026 (Jul 2026) | 3.31B | -- | 3.31B | 3.31B | 5 |
FQ2 2026 (Jun 2026) | 3.31B | -- | 3.22B | 3.4B | 9 |
FQ1 2026 (Mar 2026) | 2.99B | 3.47 | 2.91B | 3.07B | 9 |
FQ4 2025 (Oct 2025) | 3.15B | 7.75 | 3.07B | 3.24B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.65 | 1.65 | 100% | |
FQ4 2024 (Dec 2024) | 3.03 | 3.03 | 100% | |
FQ3 2024 (Sep 2024) | -1.47 | -1.47 | 100% | |
FQ2 2024 (Jun 2024) | 1.45 | 1.45 | 100% | |
FQ1 2024 (Mar 2024) | 0.56 | 0.56 | 100% | |
FQ4 2023 (Dec 2023) | 0.7 | 0.7 | 100% | |
FQ3 2023 (Sep 2023) | 1.33 | 1.33 | 100% | |
FQ2 2023 (Jun 2023) | 1.31 | 1.31 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.89B | $2887M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.9B | $2903M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.07B | $3074M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.04B | $3040M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.78B | $2784M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.86B | $2858M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.07B | $3069M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.11B | $3109M | 100% |